If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.625
Bid: 7.50
Ask: 7.75
Change: -0.50 (-6.15%)
Spread: 0.25 (3.333%)
Open: 8.125
High: 8.125
Low: 7.625
Prev. Close: 8.125
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Release of beta version of MyBrainBook®

26 May 2015 07:01

RNS Number : 1648O
IXICO plc
26 May 2015
 



 

IXICO releases beta version of MyBrainBook®

 

Putting people with dementia at the centre of decisions about their care

 

 

26 May 2015, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, today announces the release of a beta version of MyBrainBook®, its digital support platform for evaluation by people with dementia and their carers. MyBrainBook® is being made available for free evaluation during the beta phase to those who would like to start using it and contributing to its ongoing evolution and improvement as a support tool at the leading edge of digital dementia care.

 

The goal of MyBrainBook® is to put people with dementia at the centre of decisions about their care, connecting them with family, health and social care support that can enable them to live independently for longer. Further information including a video introducing MyBrainBook® is available at www.mybrainbook.com

 

The release coincides with Dementia Awareness week in the UK and the start of a nine-month pilot study with MindCare in Lewisham (part of Bromley and Lewisham Mind) which is engaging with people who have been diagnosed with dementia. 

 

Professor Derek Hill, Chief Executive of IXICO, commented:

 

"MyBrainBook® is at the heart of IXICO's evolving digital healthcare platform and one of our key initiatives to improve the lives of people being diagnosed with dementia and their families. From the outset we have been working with potential users to develop MyBrainBook® so that it is both relevant and user-friendly."

 

 

Enquiries:

 

IXICO plc

+44 20 3763 7499

Derek Hill, CEO

Susan Lowther, CFO

Charles Spicer, VP Corporate Development

FTI Consulting Limited (Investor Relations)

+44 20 3727 1000

Simon Conway

Mo Noonan

Matthew Moss

 

 

Notes to Editors

 

About MyBrainBook®

 

MyBrainBook® has been developed by IXICO as a radical new way of providing the best care to people with ementia. MyBrainBook is a digital hub which gives people with dementia and their carers the ability to build a personal profile and action plan with information they provide about the important aspects of their life. Restricted access is available to healthcare workers to ensure the appropriate support can be provided when needed.

 

More information is available on www.mybrainbook.com

 

About IXICO

 

IXICO, the brain health company, uses its innovative and proprietary digital health technologies to help those involved in researching and treating serious diseases to make rapid, informed decisions targeted at improving patient outcomes. IXICO has significant experience working with global pharmaceutical and biotechnology companies supporting clinical studies in the field of neuro-degenerative disorders including Alzheimer's disease, Huntington's disease, other causes of dementia and Multiple Sclerosis. 

 

More information is available on www.ixico.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGUPAAUPAGRA
Date   Source Headline
7th May 20247:00 amRNSNotice of half year results
15th Apr 20247:00 amRNSLife Molecular Imaging – Neuraceq Supply Agreement
3rd Apr 20247:00 amRNSImeka Collaboration Agreement
13th Mar 20247:00 amRNSTrading Update
29th Jan 202412:00 pmRNSHolding(s) in Company
25th Jan 20244:00 pmRNSResult of AGM
12th Jan 20249:35 amRNSDirectorate Change
27th Dec 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
15th Dec 20237:00 amRNSChange of Auditor
5th Dec 20237:00 amRNSFinancial Results for year ended 30 September 2023
27th Nov 20237:00 amRNSNotice of Results and Investor Presentation
5th Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
29th Sep 20237:00 amRNSTrading Update
18th Jul 20237:00 amRNSContract Win
14th Jun 20237:00 amRNSContract Win
23rd May 20237:00 amRNSHalf year report
16th May 20237:00 amRNSInvestor Meet Company presentation
10th May 20237:00 amRNSTrading Update
3rd Apr 20238:35 amRNSExtension of Huntington's disease consortium
21st Mar 202312:11 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSContract Win
7th Feb 20237:00 amRNSTrading Update
31st Jan 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
27th Jan 20231:00 pmRNSResult of AGM
3rd Jan 20237:00 amRNSTotal Voting Rights
22nd Dec 202212:18 pmRNSDirector Bed & ISA Dealing
13th Dec 20227:00 amRNSPDMR Exercise of Options
9th Dec 20229:05 amRNSContract Win
8th Dec 20223:34 pmRNSContract Update
7th Dec 20227:00 amRNSFinancial Results for the year ended 30 Sept 2022
21st Nov 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 20227:00 amRNSTrading Update
21st Sep 202210:35 amRNSHD-IH Consortium
14th Sep 20227:00 amRNSGrant of Share Options
1st Sep 20227:00 amRNSTrading Update and FY2023 Guidance
4th Aug 20227:00 amRNSContract Win
26th Jul 202211:22 amRNSContract Win - Replacement
21st Jul 20227:00 amRNSContract Win
14th Jun 20227:00 amRNSContract Extension
24th May 20227:00 amRNSHalf-year Report and Trading Update
16th May 20227:00 amRNSInvestor Presentation
10th May 20227:00 amRNSConsortium Agreement in Huntington's Disease
25th Apr 20227:00 amRNSTrading Update
21st Apr 20227:00 amRNSNew Contract Win
8th Mar 20227:00 amRNSContract worth circa £800k
14th Feb 20227:00 amRNSLaunch of IXIQ.Ai Deep learning AI-based platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.